Description
This is the second edition of a well-received book that reflects the state of the art in cancer medical therapies and their side-effects, including immunotherapy and chemotherapeutic drugs. All chapters have been fully updated to include all the latest progress in drug discovery such as targeted therapies for each cancer type. From issues such as preservation of fertility to antiemetic therapy the book provides a very comprehensive overview of the field. The book includes a new chapter on immuno-oncology drugs.
Organised by organ system, it lists the toxicity, side-effects and measures of prevention pertaining to each type of drug used in cancer therapy. The most dangerous side-effects are priority so as to alert the reader to their importance.
Designed for quick reference in the clinical setting this book is primarily aimed at established medical oncologists but will also appeal to junior doctors, trainees, pharmacists and nurses.
Table of Contents
- Updated to reflect latest progress made in drug discovery, including immunotherapy drugs
- A consistency of format from chapter to chapter to facilitate easy look-up
- Provides methods of prevention and/or treatment for the various side effects of a comprehensive sweep of systemic treatments
Table of Contents
- Drug Interactions and Pharmacogenetics – Francois Lokiec
- Breast Cancer – Matteo Lambertini, Philippe Aftimos, Andrea Gombos, Ahmad Awada, and Martine Piccart
- Lung Cancer – Solange Peters and Stefan Zimmermann
- Gastrointestinal Cancer: Selection of Clinically Relevant Drug-Induced Toxicities Encountered in Gastrointestinal Cancer Treatment – Julie Bogaert, Pieter-Jan Cuyle, and Eric VanCutsem
- Gynecologic Cancer – Sevilay Altintas and Dirk L. A. L. Schrijvers
- Side Effects of Medical Cancer Therapy in Genitourinary Malignancies – Bertrand F. Tombal, Christine Remacle, and Monique Kasa Vubu
- Central Nervous System – Patrizia Farina, Florian Scotte, Chiara Villa, Bertrand Baussart, and Anna Luisa Di Stefano
- Myeloid Malignancies – Laurent Plawny
- Lymphoma – Sigrid Cherrier-De Wilde
- Multiple Myeloma – Mario A. Dicato
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy – Caroline Robert, Christina Mateus, and Alexander M. M. Eggermont
- Immune Checkpoint Inhibition – Sarah Sammons, Megan McNamara, April K. S. Salama, and Jeffrey Crawford
- Preservation of Fertility in the Cancer Patient – Duhem Caroline and Fernand Ries
- Cardiotoxicity – I. Brana, E. Zamora, G. Oristrell, and J. Tabernero
- Bone Marrow Toxicity: Red Blood Cells – Pere Gascon
- Bone Marrow Toxicity: White Blood Cells – Matti S. Aapro
- Toxicity of Bone-Targeted Agents in Malignancy – Caroline Wilson, Fiona Taylor, and Robert Coleman
- State of the Art of Antiemetic Therapy – Sonia Fatigoni and Fausto Roila
- Side Effects of Nociceptive Cancer Pain Treatments in Adults – Ivan Krakowski and Aline Henry
- Totally Implanted Access Ports: Indications and Prevention of Complications – Didier S. Kamioner
Authors Biography
Mario Dicato, Hematology-Oncology Service at Luxembourg Medical Center, Luxembourg, and Head of the Research Laboratory of the Luxembourg Foundation for Research on Cancer and Blood Disorders. M. Dicato trained at Lausanne University, completed his postgraduate training at the Universities of Geneva, Switzerland, Pittsburgh and Yale, USA. He did his fellowship (subspecialty training) in hematology at the Massachusetts General Hospital, Boston and was Clinical and Research Fellow in Medicine at Harvard University, Boston, USA. He has published more than 250 papers and numerous book chapters, and is an editorial board member of several scientific journals.
Eric Van Cutsem, MD, PhD, is professor at the University of Leuven and head of the division of Digestive Oncology at the University Hospitals Leuven, Belgium. He trained at the University of Leuven and spent part of his training in Lausanne, Bristol, San Antonio and Rotterdam. He published more than 500 peer-reviewed articles. He is member of the Belgian Royal Academy of Medicine and president of the Belgian Foundation Against. He is/was a committee or board member of several international scientific organizations, including ESMO, ASCO, EORTC, UEG, ESDO, ENETS.
Additional information
| Weight | 7.737 kg |
|---|
Only logged in customers who have purchased this product may leave a review.
Related Products








Reviews
There are no reviews yet.